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Abstract
Objective: To record and analyze complication rates following postpartum  intrauterine 
device (PPIUD) insertion in 48 hospitals in six countries: Sri Lanka, India, Nepal, 
Bangladesh, Tanzania, and Kenya.
Methods: Healthcare providers were trained in counselling and insertion of PPIUD via 
a training- the- trainer model. Data were collected on methodology, timing, cadre of 
staff providing care, and number of insertions. Data on complications were collected 
at 6- week follow- up. Statistical analysis was performed to elucidate factors associated 
with increased expulsion and absence of threads.
Results: From May 2014 to September 2017, 36 766 PPIUDs were inserted: 53% 
vaginal and 47% at cesarean delivery; 74% were inserted by doctors. Follow- up was 
attended by 52%. Expulsion and removal rates were 2.5% and 3.6%, respectively. 
Threads were not visible in 29%. Expulsion was less likely after cesarean insertion 
(aOR 0.33; 95% CI, 0.26–0.41), following vaginal insertion at between 10 minutes and 
48 hours (aOR 0.59; 95% CI, 0.42–0.83), and when insertion was performed by a 
nurse (aOR 0.33; 95% CI, 0.22–0.50).
Conclusion: PPIUD has low complication rates and can be safely inserted by a variety 
of trained health staff. Given the immediate benefit of the one- stop approach, 
 governments should urgently consider adopting this model.
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1  | INTRODUCTION
The postpartum period is recognized as a timeframe that has high 
unmet need for contraception, with limited choices available to 
women.1 An increasing focus in recent years has been on the oppor-
tunity provided by facility births to meet this need and overcome the 
significant challenge of barriers to access.2 Offering insertion of a 
postpartum intrauterine device (PPIUD) prior to discharge after a facil-
ity birth may be a particularly convenient option for eligible women, 
with the distinct advantages of long- term nature, reversibility, and less 
follow- up required.3
Existing research into how PPIUD programs are delivered, in par-
ticular the significance of provider cadre and insertion technique, 
remains limited. Data assessing the impact of provider status on 
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patient outcomes is of notable importance in an environment where 
task- sharing among doctors, midwives, and other healthcare pro-
fessionals is increasingly used to expand and deliver family planning 
services.4 Current available evidence is supportive of task- sharing in 
PPIUD provision. One case- control study analyzing secondary data 
from a PPIUD program in India found no association between pro-
vider cadre and adverse outcomes such as expulsion or infection.5 This 
remains to be demonstrated across a variety of settings.
There is currently no consensus in the literature on methods of 
insertion of PPIUD. Common insertion techniques include manual 
insertion, Kelly forceps, ring forceps, and dedicated PPIUD insert-
ers.6–8 It has been posited that high fundal placement, which can be 
achieved either manually or with instruments such as Kelly forceps or 
a dedicated PPIUD inserter, may be desirable to minimize expulsion 
rates.6,7 However, many existing studies on PPIUD do not describe 
the methods used, or simply characterize the insertion as instrumen-
tal versus manual. More research is imperative to guide and optimize 
delivery of PPIUD in family planning services.
Interpreting data on complication rates following PPIUD insertion 
is equally problematic for service providers. While rates of infection 
and perforation following insertion are consistently low,9 the authors 
of a 2015 Cochrane review called for more research assessing expul-
sion rates.10 Existing studies vary hugely in their rates of expulsion 
after PPIUD insertion, from under 2% to over 25%.6,11 Comparisons 
are made even more challenging by inconsistencies in definition of 
expulsion (complete vs incomplete) and timing of follow- up. In addi-
tion, very few studies have included rates of lost threads with IUDs in 
situ after insertion. This complication has the potential to cause signif-
icant patient anxiety, particularly where access to follow- up services 
such as ultrasonography may be problematic.
Thus, the question at the core of current debate around PPIUD 
remains: to what extent does PPIUD represent a trade- off of conve-
nience and usefulness versus potential complications?10 More evi-
dence is essential to enable healthcare professionals to counsel their 
patients and expand contraceptive choices for women in the postpar-
tum period. The present article describes experiences gained from a 
FIGO initiative to provide PPIUD in 48 facilities across six low- and 
middle- income countries. Data are included on insertion timing and 
technique, provider cadre, and subsequent rates of complications at 
the 6- week postnatal check including infection, expulsion, and lost 
threads. To the authors’ knowledge, this is one of the largest studies in 
the literature on this subject to date.
2  | MATERIALS AND METHODS
The FIGO PPIUD initiative started in Sri Lanka in July 2013 where six 
facilities were chosen to take part in a pilot project. Following suc-
cessful implementation, the initiative expanded in 2015 to a further 
12 hospitals in Sri Lanka and six facilities in each of five additional 
countries: Tanzania, Kenya, Nepal, Bangladesh, and India. The coun-
tries were chosen based on contraceptive prevalence, unmet need 
for contraception, presence of an obstetrics and gynecology national 
society willing to work with FIGO, and governments that were accept-
ing of PPIUD.
The facilities selected in each country were referral hospitals with 
over 5000 deliveries per year. Meetings were held with senior clini-
cians and hospital managers to explain the health benefits of birth 
spacing and the advantages of PPIUD. Following this, a training- of- 
trainers model was used to train providers in family planning counsel-
ling and PPIUD insertion techniques following vaginal and cesarean 
deliveries. This involved teaching a core of 12–18 master trainers, who 
would then go on to repeat the training sessions in their own facilities.
All six countries were given the same training materials, which 
included a standard set of slides, training videos, and outlines for prac-
tical sessions including role plays for counselling and Mama- U models 
(Laerdal, Stavanger, Norway),12 with accompanying clinical equipment 
for insertion of PPIUD. A FIGO minimal training standards document 
was shared and adhered to by all countries to ensure standardization.
Following correct practice insertions on the Mama- U model, each 
provider had to perform supervised insertions on a live patient fol-
lowed by unsupervised successful insertions before being signed off 
as competent. The thresholds set varied from country to country as 
skill level and cadres of health staff were different. A unique identifier 
number allowed their progress to be tracked over the course of the 
initiative. Facility mentors could then follow up their trainees’ achieve-
ments over time.
A total of 4904 providers were trained in counselling and insertion 
over the period studied. Not all of these providers went on to be pro-
ductive as many were clinical managers not directly providing services. 
It was nevertheless important to include them to gain support for the 
initiative. All providers were trained in providing balanced counselling 
where all available methods of family planning, including PPIUD were 
discussed. In India, Nepal, and Bangladesh, additional family planning 
counsellors were employed by the initiative as clinical staff were over-
loaded and could not spend sufficient time counselling women. These 
counsellors were employed from the start in India, but midway through 
the project in Nepal and Bangladesh. Women were counselled prena-
tally (preferably at multiple clinic encounters), in early labor (if it was 
felt appropriate), and also immediately postpartum (within 48 hours 
of birth). Consent for insertion was taken at any of these encounters.
For vaginal deliveries, the insertion technique taught used the 33 cm 
long, curved Kelly hemostatic forceps (Sklar Surgical Instruments, West 
Chester, PA, USA) that ensure high fundal insertion. This technique has 
been well described in the literature.6,9,10,13–15 Timing of insertion after 
vaginal delivery was categorized as either postplacental (within 10 min-
utes of delivery of the placenta) or immediate postpartum (within 
48 hours) (Table 1). Insertion after 48 hours was not recommended 
owing to the known higher risk of complications.3 Cadre of health staff 
trained in insertion varied from country to country (Table 2).
Women were asked to return for follow- up at 6 weeks postpar-
tum so that information on adverse effects and complications could be 
obtained. The majority of women attended at around the 6- week mark 
as this was the recommended time to return. No cases were excluded 
from the analysis if they returned before or after 6 weeks. As a result 
of low face- to- face follow- up rates, telephone follow- ups were also 
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conducted in all six countries. Those who were followed up by tele-
phone could not have a speculum examination, nor could the same 
level of detail be ascertained with regard to complaints. However, this 
was preferable to having no information on outcomes. Missing data 
are acknowledged in the results tables.
Women delivering in those facilities taking part in the initiative 
were asked for their consent to take part in a short 15- minute face- to- 
face structured interview. In those cases where consent was obtained, 
in- country data collection officers (DCOs) conducted the interview 
prior to their discharge from hospital following birth.
Healthcare providers seeing women at the 6- week follow- up were 
asked to fill in a follow- up questionnaire. Data were entered using 
tablets and stored in a CommCare database (Dimagi, Cambridge, MA, 
USA). Univariate and multivariate analyses were performed using 
Stata version 15.0 software (StataCorp LLC, College Station TX, USA). 
When looking at expulsion rates and missing threads, factors adjusted 
for were country, cadre of health staff, and method of insertion. It was 
not possible to adjust by experience of provider; however, as PPIUD 
services were new in all facilities, if provider experience had affected 
expulsion rates then this should have been the same across all sites.
An external evaluation of the initiative was conducted by the 
Harvard School of Public Health over a 1- year period in three of the six 
countries (Nepal, Tanzania, and six facilities in Sri Lanka). These data 
are also included in the overall analysis. The questionnaires used were 
slightly different, as were follow- up rates in the two sets of data. The 
Harvard questionnaire was longer with more detailed questions about 
the service provided and included longer follow- up. This analysis only 
reports outcomes at 6 weeks across both data sets where the ques-
tions asked were the same, making it possible to amalgamate and 
interpret the data. The FIGO PPIUD initiative did not follow up women 
who had a PPIUD inserted after the 6- week postnatal check.
Data were anonymized and appropriate ethics committee approv-
als were obtained from the respective country’s institutions, as well as 
from the London School of Hygiene and Tropical Medicine for analysis 
and publication.
3  | RESULTS
From May 2014 to September 2017, a total of 725 647 deliveries 
occurred in the 48 facilities participating in the initiative. Following 
counselling and consent, a total of 36 766 PPIUD insertions were 
undertaken: 53% performed following vaginal and 47% follow-
ing cesarean delivery, although this varied from country to country 
(Fig. 1). A total of 27 395 insertions were performed by doctors, 5695 
by nurses, and 2969 by midwives (Fig. 2). In Sri Lanka, all insertions 
were performed by doctors, whereas in other countries vaginal inser-
tions were also performed by midwives, nurses, and other profession-
als. In Kenya and Tanzania, the majority of vaginal insertions were 
performed by midwives. In one facility in India, nurses performed 
4326 vaginal insertions, totaling 26% of all insertions done in the 
country, whereas in the remaining five facilities insertions were con-
ducted by doctors only. In Nepal, skilled birth attendants (classified 
as “Other”) contributed to 19% of insertions. In Bangladesh, although 
TABLE  1 Categorization of timing of PPIUD insertion after delivery.
Delivery type Timing of insertion
Vaginal Postplacental Within 10 min of placental delivery Insertion conducted using 33 cm long curved Kelly forceps 
to ensure high fundal placement
Immediately 
postpartum
Between 10 min and 48 h after 
placental delivery
Insertion conducted using 33 cm long curved Kelly forceps 
to ensure high fundal placement
After 48 h 48 h after placental delivery Not recommended owing to increased risks of 
complications
Cesarean Intraoperative Following delivery of placenta Insertion is under direct vision through the uterine incision. 
Can be performed manually or using instruments
TABLE  2 Cadres of health staff trained in PPIUD insertion.
Cadre of 
health staff Description
Doctor Includes both junior and senior doctors working on maternity wards. Senior doctors are obstetrics and gynecology specialists and 
junior doctors are those who have not completed specialist training
Nurse Includes all staff with a nursing degree working on maternity wards. In this study the vast majority were from India with either a 
General Nursing and Midwifery course (3 y) or Bachelor in Science Nursing (4 y). There were no Auxiliary Nurse Midwives (1–2 y 
course)
Midwife Includes all midwives and nurse- midwives with degrees or diplomas. In this study these were from Tanzania and Kenya. In Kenya, all 
nurses receive comprehensive midwifery training and were therefore classified as midwives
Clinical 
Officer
Practicing in Kenya and Tanzania. These are nonphysician healthcare professionals with 3–4 y diplomas who function like doctors and 
occasionally work on maternity wards. Tanzanian assistant medical officers were also included in this category. These have 2 y 
additional clinical training to achieve an advanced diploma
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midwives contributed in some facilities, the vast majority of insertions 
were performed by doctors. Only 46 insertions were performed by 
clinical officers, which were also classified as “Other”.
Across all six countries, PPIUD was successfully inserted in 98% of 
cases. When inserted successfully, 97% of these insertions occurred 
after one single attempt. At vaginal insertion, Kelly forceps were used 
in 15 499 cases (87%) with 924 insertions occurring manually (5%). 
Complications during insertion were reported in 134 cases out of a 
total of 36 697 insertions with data available (Table 3). The most com-
mon complication was heavy bleeding at the time of insertion (0.14%). 
No perforations were recorded.
Women attended follow- up in 52% of cases. Among completed 
interviews, approximately 49% were followed up by face- to- face 
interview and 51% were followed up by telephone. Table 4 demon-
strates the distribution by type of insertion of women who attended 
for follow- up compared with those who did not.
Overall outcomes are presented in Table 5. Expulsion rates varied 
from 1.2% in Tanzania to 4.3% in Kenya. Removal rates also varied 
from 2.6% in India and Kenya to 8.3% in Tanzania. Overall expulsion 
and removal rates were 2.6% and 3.7%. The most common complaint 
was persistent vaginal discharge in 6.9% of cases and the second most 
common was abdominal pain (4.4%), as outlined in Table 6. Strings 
were visible in 71% of cases.
Table 7 presents the results of univariate and multivariate analy-
sis of expulsions stratifying by type of insertion (vaginal or cesarean 
delivery), cadre of inserter, and timing of insertion following vaginal 
delivery. Following cesarean delivery, after adjusting for country, 
women were 67% less likely to have an expulsion than following inser-
tion after vaginal delivery (aOR 0.33; 95% CI 0.263–0.406). Looking 
at the timing of insertion following vaginal delivery, after adjusting 
for country and method of insertion, expulsion was 41% less likely if 
it occurred between 10 minutes and 48 hours after placental vaginal 
delivery as opposed to within 10 minutes of vaginal delivery of the pla-
centa (aOR 0.59; 95% CI 0.002–0.417). Vaginal insertions conducted 
by nurses were 67% less likely to result in an expulsion when com-
pared with senior doctors after adjusting for country and method of 
insertion (aOR 0.33; 95% CI 0.216–0.495). There was no difference 
detected across other cadres.
After adjusting for country and cadre, IUD threads were significantly 
less likely to be seen following insertion intraoperatively at cesarean 
delivery (aOR 2.88; 95% CI 2.496–3.316) than following vaginal delivery.
F IGURE  1 Timing of PPIUD insertion across the six countries 
participating in the initiative. [Colour figure can be viewed at 
wileyonlinelibrary.com]
0% 20% 40% 60% 80% 100%
Sri Lanka
Bangladesh
India
Nepal
Kenya
Tanzania
Total
Timing of PPIUD Inseron
<10 mins
10 mins to 48hrs
Intraoperavely at cesarean
F IGURE  2 Cadre of health provider performing PPIUD insertion 
by country. [Colour figure can be viewed at wileyonlinelibrary.com]
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Others
TABLE  3  Information on insertions (n=37 383) across all six 
countries.
No. %
PPIUD successfully inserted
 Yes 36 766 98
 No 615 2
 (Missing data 2)
Number of attempts
 Single 35 484 97
 Multiple 1194 3
 (Missing data 705)
Method used at vaginal insertion (n=19 786)
 Kelly forceps 15 499 87
 Ring forceps 189 1
 Manually 924 5
 Other 1202 7
 Total 17 814
 (Missing data 1972)
Complications at insertion (multiple responses allowed n=36 697)
 Heavy bleeding 50 0.14
 Severe pain 29 0.08
 Perforation 0 0.00
 Other 11 0.03
 No explanation given 49 0.13
 Total complications occurring 134 0.37
 (Missing data 686)
TABLE  4 Type of insertion among women who did and did not 
attend follow- up 6 weeks after PPIUD insertion.
Type of insertion
Attendance at follow- up, %
TotalNo Yes
Vaginal
 <10 min 48.9 36.4 42.6
 10 min and 48 h 8.3 11.2 9.8
 >48 h 0.6 0.6 0.6
Cesarean 42.2 51.8 47.1
No. 18 423 18 960 37 383
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4  | DISCUSSION
The data collected over the course of this initiative is vast, which 
strengthens its scientific value. Nevertheless, it is important to rec-
ognize some limitations. First, all the facilities involved in the ini-
tiative are large referral units of over 5000 births per annum. One 
must therefore exert caution in generalizing the findings to smaller 
peripheral hospitals. However, it is interesting to note that from an 
implementation perspective, the initiative seemed to work best in 
the smaller referral institutions where initial buy in, as well as train-
ing and monitoring were much easier to achieve. One could pos-
tulate that it may be easier to roll out in smaller units and achieve 
more impressive results. A second limitation was that not all women 
were followed up, and these rates varied from country to country. 
Analysis of the characteristics of the two groups showed some dif-
ferences with a slightly higher proportion of women who had a 
cesarean delivery in the follow- up group (52% vs 42%; P<0.001). 
This is to be expected, as these women would be more likely to 
attend for postnatal follow- up given their postoperative state. 
Outcomes at 6 weeks could therefore be skewed toward those 
expected following insertion after cesarean. Multivariate analysis 
did demonstrate a lower expulsion rate after insertion at cesarean 
delivery compared with following vaginal delivery, and this should 
be taken into account. One could also postulate that women would 
be more likely to attend for follow- up if they had encountered prob-
lems or wanted the IUD removing, which would make complication 
rates higher in the follow- up than in the lost- to- follow- up group. 
However, this is the opinion of the authors and cannot be accu-
rately ascertained.
Despite these limitations, analysis of the data was possible and 
it is interesting to interpret the results. The data demonstrate that 
PPIUD is a safe and acceptable form of contraception. Success rates 
of insertion were 98%, and only 3% required more than one attempt 
at insertion. There were few recorded complications during insertion, 
with heavy bleeding at insertion being the main complaint (0.14%). 
No perforations were recorded. This is to be expected as the immedi-
ate postpartum uterus differs greatly from the nonpregnant uterus—
which is at known risk of perforation during interval insertion. The 
large, thick walls of the immediate postpartum uterus make perfora-
tion highly unlikely.
The follow- up data suggest that adverse effects were also uncom-
mon. Vaginal discharge and abdominal pain were the most common 
complaints (6.9% and 4.4%, respectively). Pelvic inflammatory disease 
(PID) requiring hospital admission and intravenous antibiotics was 
rare, with only 12 recorded cases (0.1% of total insertions). One out of 
the six countries had a policy of giving a short course of antibiotics to 
TABLE  5 Details of outcomes following PPIUD insertion for each country participating in the initiative.
Sri Lanka Bangladesh India Nepal Kenya Tanzania All countries
Period of time 
monitored
1 May 2014 to 
30 Sep 2017
7 Nov 2015 to 
30 Sep 2017
1 Dec 2015 to 
30 Sep 2017
1 Dec 2015 to 
30 Sep 2017
24 Sep 2015 to 
30 Sep 2017
11 Mar 2016 to 
30 Sep 2017
No. facilities 18 6 6 6 6 6 48
No. deliveries 291 861 87 951 72 195 119 844 72 340 81 456 725 647
No. providers trained 932 1014 914 210 1007 827 4904
No. insertions 8055 5255 16 643 2503 1651 2659 36 766
No. followed up 3375 2829 8786 2091 716 1163 18 960
Follow- up rate, % 42 54 53 84 43 44 52
No. expulsionsa 66 84 198 80 27 14 469
Expulsion rate, % 2.3 3.3 2.3 3.9 4.3 1.2 2.6
No. removalsb 121 71 229 150 16 95 682
Removal rate, % 3.7 2.8 2.6 7.4 2.6 8.3 3.7
aMissing data in 850 from 18 960 reports collected on expulsion (rates calculated excluding missing data).
bMissing data in 526 from 18 960 reports collected on removals (rates calculated excluding missing data).
TABLE  6 Follow- up across all six countries (n=18 960).
No. %
Adverse effects reported
 Yes 3711 22
 No 13 302 78
 (no data 1947)
Adverse effects
 Vaginal discharge 1177 6.9
 Abdominal pain 742 4.4
 Irregular bleeding 403 2.4
 Threads not palpable 437 2.6
 Threads coming out of vagina 147 0.9
 Pelvic inflammatory disease 12 0.1
 Other 292 1.7
Speculum examination (face- to- face only: n=11 326)
 Strings visible 5940 71
 Strings not visible 2405 29
 (Missing data 2981)
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all women who had an IUD inserted, which may also have contributed 
to the low rates of PID. However, the questionnaire was not well set 
up for recording mild infections. Complaints of vaginal discharge and 
abdominal pain could indicate a mild infection and this would not have 
been picked up in this study.
Interestingly, 147 cases (0.9%) of follow- ups mentioned threads 
coming out of the vagina as a complaint. Threads were not trimmed 
at insertion and it was always a concern that this could occur. Women 
were advised of the potential risk, and were asked to return for the 
threads to be trimmed if this happened, but it appears also to be a rare 
complaint. Absence of strings was more common, and was recorded 
in 29% of cases that were followed up with a speculum examination.
Further statistical analysis demonstrated that missing threads 
were 2.88 times more common following insertion after cesarean 
delivery. During cesarean, the provider must make an extra attempt to 
straighten the threads once insertion has occurred; following vaginal 
insertion the threads should naturally sit at the cervical os. Although 
laying threads is the standard protocol at cesarean delivery, it is an 
extra step, and one that providers might forget. This could explain the 
difference. All healthcare providers trained in insertion were also pro-
vided with information on the benefits of using a thread retriever and 
the need for ultrasound in cases where it was not possible to confirm 
the location of the PPIUD. However, in reality, thread retrievers and 
ultrasound machines were not readily available in many of the facili-
ties involved in the initiative and this needs to be taken into account 
during future implementation. There may have been a slightly higher 
rate of invasive procedures such as hysteroscopy to retrieve IUDs with 
lost threads. However, the data were not set up to analyze this further.
The data also demonstrate that insertion can be safely achieved 
by a variety of health staff and need not be limited to doctors. Task- 
sharing to nurses and midwives was safely and effectively performed in 
all participating countries other than in Sri Lanka. In Sub- Saharan Africa, 
midwives and nurse- midwives have taken on a variety of additional 
roles, increasing access to health care that would otherwise have been 
limited to those fortunate enough to have care provided by doctors.
With low doctor:patient ratios in several countries, task- sharing 
is an essential strategy ratified by the WHO.16 In Kenya and Tanzania, 
midwives performed 94% of all vaginal insertions. Statistical analysis 
demonstrated that there is no difference in expulsions rates between 
insertions of PPIUD by senior doctors and midwives and, therefore, 
this skill can be safely added to their list of competencies. In India, one 
out of the six facilities was able to expand training to nurses working 
on maternity wards. The impact in this one institution was dramatic, 
with a sudden increase in insertion rates as the service became more 
available to women with normal vaginal deliveries who are often in and 
out of the facility too rapidly for doctors to intervene.
TABLE  7 Statistical analysis of PPIUD expulsion and missing thread data.
Univariate analysis Multivariate analysis
Crude OR P>z 95% CI aOR P>z 95% CI
Type of deliverya
 Vaginal 1.00 1.00
 Cesarean 0.43 <0.001 0.354–0.525 0.33 <0.001 0.263–0.406
 No. 18 110 18 110
After vaginal deliveryb
 Timing of insertion
 <10 min 1.00 1.00
 10 min to 48 h 0.67 0.009 0.492–0.903 0.59 0.002 0.417–0.825
 Cadre of staff
 Senior doctor 1.00 1.00
 Junior doctor 1.27 0.089 0.964–1.685 0.93 0.654 0.659–1.299
 Nurse 0.62 0.007 0.440–0.876 0.33 <0.001 0.216–0.495
 Midwife 0.78 0.239 0.516–1.179 0.41 0.164 0.117–1.441
 Others 1.52 0.061 0.981–2.365 0.52 0.028 0.295–0.932
 No. 8664 8664
Missing threadsc
 Type of delivery
 Vaginal 1.00 1.00
 Cesarean 1.30 <0.001 1.181–1.429 2.88 <0.001 2.496–3.316
 No. 8345 8345
aMultivariate analysis adjusting for country.
bMultivariate analysis adjusting for country and method of insertion.
cMultivariate analysis adjusting for cadre and country.
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Analysis also demonstrated that insertions by nurses were less 
likely to result in expulsion compared with insertions performed by 
senior doctors. Perhaps their skills with normal vaginal insertions sur-
pass those of the senior doctor. In all countries where other health 
cadres perform insertions, insertions occur more frequently follow-
ing vaginal delivery than following cesarean. Doctors are not always 
available immediately following vaginal deliveries as they are during 
cesarean, where they tend to be the main providers. Therefore, PPIUD 
became more accessible to all women.
Expulsion rates and removal rates varied from country to country 
and our experience monitoring this initiative suggests that removal 
rates depended on the quality of counselling. Women were less likely 
to ask to have the IUD removed at follow- up if inclusive and compre-
hensive counselling had been undertaken prior to insertion. In Nepal 
this has been a problem throughout the initiative, with removal rates 
always slightly higher than in the other countries. High volume of 
patient to staff ratios and reliance on group counselling may explain 
this. Compared with the other five countries, Nepal trained fewer 
providers (only 210) owing to restrictions by the government on who 
could be trained. Another postulated reason is that Nepal has a large 
migrant population where husbands often work abroad, leaving their 
wives alone during pregnancy and only returning briefly for the birth 
of the child. Consequently, they were not present during counselling 
sessions and often objected to the method once they returned home, 
particularly given their perception that once they had left their wife to 
return to work, there was no more need for contraception.
Tanzania also had a high removal rate, but interestingly, a very low 
expulsion rate. Some removals were reported to have been under-
taken due to partial expulsion. Unfortunately, the questionnaire was 
not robust enough to pick up these subtleties, but it may be that a pro-
portion of the removals were in fact partial expulsions. There was also 
concern that visualization of the stem of the IUD in the cervical canal 
may have been erroneously construed as a partial expulsion, resulting 
in an unnecessary removal.
Overall expulsion rates were much lower than those recorded in 
the literature. However, expulsion and removal rates are very similar 
to those published by Pfitzer et al.2 who also conducted an implemen-
tation study across six countries3 using the same methodology for 
insertions. There is a general perception that high expulsion rates are 
a consequence of the inability of the inserter to place the PPIUD high 
at the uterine fundus. Insertion during cesarean delivery is straightfor-
ward given that the inserter has the uterus open and is therefore able 
to place the PPIUD under direct vision.
During training it was evident that for vaginal insertions, using the 
Kelly forceps takes skill in ensuring that the PPIUD is correctly positioned. 
Consequently, during monitoring and evaluation throughout the life of 
the initiative it was observed that all the countries showed a learning 
curve when teaching the technique to new trainees. As experience and 
expertise increased, expulsion rates dropped. When staff moved on and a 
new batch was trained, expulsion rates would rise again. It is not surpris-
ing then that the data demonstrated that expulsion is 67% less likely fol-
lowing insertion during cesarean than following vaginal insertion. Overall, 
expulsion rates after vaginal delivery were 3.6%, which is similar to the 
rate of approximately 5% reported following interval insertion.17 PPIUD 
should therefore not be limited to women undergoing a cesarean.
Timing of insertion after vaginal delivery also appears to have an 
impact on expulsion rates. Expulsions were slightly less likely if PPIUD 
was inserted between 10 minutes of placental delivery and 48 hours 
rather than within 10 minutes of placental delivery. It may well be that 
the uterus has had more time for involution at between 10 minutes 
and 48 hours and have progressively less frequent uterine contrac-
tions and blood flow, which may have contributed to a lower chance 
of expulsion. It may also be easier to correctly place the IUD at the 
fundus with a more involuted uterus. However, expulsion rates when 
insertion occurred within 10 minutes of placental delivery are not high 
enough to warrant that this practice should be replaced by later inser-
tion. A “one- stop” procedure following delivery is more efficient and is 
likely to be more attractive to women who may be reluctant to return 
for a second procedure within 48 hours of delivery.
5  | CONCLUSION
The vast data from this initiative of over 36 000 recorded insertions col-
lected across six different countries have demonstrated that PPIUD is 
a safe and effective method of contraception that can be delivered by 
a variety of cadres of health staff. Although expulsion rates are lower 
when inserted intraoperatively at cesarean delivery, they are still low 
and comparable to interval IUD insertion when inserted within 48 hours 
of vaginal delivery. Given the immediate benefit of a one- stop approach 
for women who struggle to return to health facilities after giving birth, 
governments should consider adopting PPIUD into the mix of contra-
ceptive methods currently offered as a matter of urgency. Given that the 
copper IUD is cost- effective and readily available, the only extra issue 
with implementation is training healthcare providers in counselling and 
insertion, which this initiative has demonstrated to be highly feasible.
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